A patient priority list is evidence about preferences rather than a clinical risk estimate.
The web-cohort study asked 691 participants to select a top-five list from fifteen procedures previously identified by clinicians. Benzodiazepine and related-agent prescribing ranked among priorities for reducing overuse. Effectiveness, tolerability and recommendations influenced choices more often than cost.
The sample was self-selected, and the candidate list and explanatory material shaped responses. A ranking does not determine whether an individual prescription was unnecessary. The survey did not measure withdrawal, treatment response or the incidence of adverse events.
For evaluating a quality-improvement proposal, distinguish stakeholder priorities from efficacy evidence. Patient involvement can identify concerns worth addressing, but it cannot independently resolve a specific benzodiazepine’s benefit–risk balance. The study supports discussion and service planning rather than a blanket inference of inappropriate care.
Source: Publication PMC8235619. Applications to expert review are interpretive analysis.
Related reading: Patient–Psychiatrist Survey Found Disagreement in Both Directions About Benzodiazepine Reduction.